Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment.

Turshudzhyan, Alla; Vredenburgh, James

Turshudzhyan, Alla; Vredenburgh, James.

Turshudzhyan A; Department of Internal Medicine, University of Connecticut, Farmington, CT, USA.
Vredenburgh J; Hematology and Oncology Department, Saint Francis Hospital, Hartford, CT, USA.

J Oncol Pharm Pract ; 27(7): 1770-1774, 2021 Oct.

Article en En | MEDLINE | ID: mdl-33435824

Asunto(s)

Neoplasias de la Mama; Maitansina; Ado-Trastuzumab Emtansina; Anticuerpos Monoclonales Humanizados; Neoplasias de la Mama/tratamiento farmacológico; Femenino; Humanos; Maitansina/uso terapéutico; Receptor ErbB-2; Trastuzumab/uso terapéutico

Palabras clave

HER2; ado-trastuzumab emtansine; breast cancer

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Maitansina Tipo de estudio: Guideline / Qualitative_research Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google